文献速递慢阻肺

母亲吸烟与CC-16:对肺发育及全生命周期COPD的影响

Maternal smoking and CC-16: implications for lung development and COPD across the lifespan.
PubMed 文献 · Am J Respir Crit Care Med · 2026-01-01

研究分析4个人类队列(COPDGene n=1062、ECLIPSE n=2164、ALLIANCE n=63、LTRC n=44)及小鼠模型,发现母亲吸烟与循环和气道CC16降低相关,伴上皮损伤增加;rhCC16可通过α2-整合素结合恢复小鼠胚胎肺分支。母亲吸烟所致CC16减少可能扰乱肺发育, predispose终身肺功能受损和更差COPD结局。

要点

  • 母亲吸烟与子代循环及气道CC16水平降低相关,在COPD患者、对照和临床前小鼠模型中均可见。
  • 人类成人中较低CC16与加速的肺功能下降和肺气肿进展相关;儿童中与阻塞性生理和早期小气道损伤相关。
  • 小鼠胚胎肺外植体中吸烟损害肺分支,rhCC16可通过α2-整合素结合恢复分支。

核心结论

  • 母亲吸烟降低CC16水平,扰乱肺发育, predispose终身肺功能受损和更差COPD结局。
  • 明确CC16调控肺成熟的机制对于建立可靠结局指标和设计预防早期COPD的试验至关重要。

研究设计与样本

  • 分析4个人类队列:COPDGene血浆(n=1062)、ECLIPSE血浆(n=2164)、ALLIANCE鼻刷(n=63)、LTRC外周肺切片(n=44),均有或无母亲吸烟暴露史。
  • 使用WT和Cc16-/-小鼠评估肺组织学和呼吸力学,并有或无母亲吸烟暴露。
  • 在胚胎小鼠肺外植体中评估重组人CC16(rhCC16)对肺成熟的影响。

主要发现

  • 母亲吸烟与COPD患者、对照和临床前小鼠COPD模型中循环及气道CC16降低相关。
  • 人类成人中较低CC16与加速的肺功能下降和肺气肿进展相关;儿童中与阻塞性生理和早期小气道损伤相关。
  • 小鼠和人类中,母亲吸烟诱导的CC16降低伴随更重上皮损伤(纤维化、炎症、凋亡和氧化应激)。
  • 小鼠外植体中吸烟损害肺分支,而rhCC16通过α2-整合素结合恢复分支。

临床怎么用

  • 母亲吸烟史可作为子代CC16降低和肺发育受损的风险标志,提示需关注早期肺功能轨迹。
  • CC16可能作为评估肺发育和COPD风险的候选生物标志物,但需进一步验证。
  • rhCC16恢复肺分支的发现提示其作为干预靶点的潜在价值,尚需临床试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Early-life lung function trajectories predict long-term respiratory health, including COPD risk. Club Cell protein 16 (CC16) is a key determinant of lung health, with low levels associated with impaired lung development, reduced lung function, and COPD. Cigarette smoking lowers CC16, but it is unknown whether maternal smoking leads to persistent CC16 deficiency from early life, thereby disrupting lung development and predisposing to COPD risk and progression. METHODS: CC16 expression was analyzed across 4 human cohorts, in plasma samples (COPDGene [n = 1062] and ECLIPSE [n = 2164]), nasal brushings (ALLIANCE [n = 63]), and peripheral lung sections (LTRC [n = 44]) from participants with and without a history of maternal smoking exposure. Lung histology and respiratory mechanics were assessed in WT and Cc16-/- mice with and without maternal smoking exposure. Recombinant human (rh)CC16 effects on lung maturation were assessed in embryonic murine lung explants. RESULTS: Maternal smoking was linked to reduced circulating and airway CC16 in COPD patients, controls, and a preclinical murine COPD model. In human adults, lower CC16 correlated with accelerated lung function decline and emphysema progression, while in children it was associated with obstructive physiology and early small airway impairment. In both mice and humans, maternal smoking-induced CC16 reduction was accompanied by greater epithelial injury (fibrosis, inflammation, apoptosis, and oxidative stress). In murine explants, smoking impaired lung branching, whereas rhCC16 restored branching via α2-integrin binding. CONCLUSIONS: Maternal smoking reduces CC16 levels, disrupting lung development in ways that predispose to lifelong impairment of lung function and worse COPD outcomes. Defining the mechanisms by which CC16 regulates lung maturation is essential for establishing reliable outcome measures and designing trials aimed at preventing early COPD.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Rojas-Quintero J, Faner R, Chiu CY, et al. Maternal smoking and CC-16: implications for lung development and COPD across the lifespan. Am J Respir Crit Care Med. 2026. PMID: 41056135. doi:10.1164/rccm.202504-0854OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。